Smyczek Petra, Singh Ameeta E, Romanowski Barbara
Department of Medicine, University of Alberta, Edmonton, Canada.
Int J STD AIDS. 2013 Nov;24(11):843-51. doi: 10.1177/0956462413481527. Epub 2013 Jul 10.
Anal cancer is a rare malignancy of the distal gastrointestinal tract, often associated with human papillomavirus, the most common sexually transmitted infection worldwide. Currently available screening methods for anal intraepithelial neoplasia, a precursor for anal cancer, combine anal Papanicolaou cytology and high resolution anoscopy with biopsy of suspicious lesions. Significant barriers to establishing anal cancer screening programmes include the small number of healthcare professionals performing high resolution anoscopy and the lack of data showing that anal cancer screening can reduce morbidity and mortality related to anal carcinoma. Despite several controversies surrounding anal cancer screening, the rising incidence of this disease in some groups supports routine screening programmes in high-risk populations, especially in HIV-positive men who have sex with men. This review outlines the epidemiology of anal intraepithelial neoplasia and anal cancer and summarizes issues related to the introduction of anal cancer screening programmes.
肛管癌是一种发生于消化道远端的罕见恶性肿瘤,常与人乳头瘤病毒相关,人乳头瘤病毒是全球最常见的性传播感染病原体。目前用于筛查肛管上皮内瘤变(肛管癌的癌前病变)的方法,是将肛管巴氏细胞学检查与高分辨率肛门镜检查相结合,并对可疑病变进行活检。建立肛管癌筛查项目存在的重大障碍包括:进行高分辨率肛门镜检查的医疗专业人员数量较少,以及缺乏数据表明肛管癌筛查可降低肛管癌相关的发病率和死亡率。尽管围绕肛管癌筛查存在一些争议,但该疾病在某些人群中的发病率不断上升,这支持在高危人群中开展常规筛查项目,尤其是在男男性行为的HIV阳性者中。本综述概述了肛管上皮内瘤变和肛管癌的流行病学情况,并总结了与引入肛管癌筛查项目相关的问题。